Armistice Capital, LLC 13D/13G Filings for Intensity Therapeutics, Inc. (INTS)

Armistice Capital, LLC 13D and 13G filings for Intensity Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-05-15
3:28 pm
Sale		 2025-03-31 13G Intensity Therapeutics, Inc.
INTS		 Armistice Capital, LLC 872,547
5.750%		 -254,321decrease
(-22.57%)		 Filing
2025-02-14
5:29 pm
Purchase		 2024-12-31 13G Intensity Therapeutics, Inc.
INTS		 Armistice Capital, LLC 1,126,868
8.130%		 1,126,868increase
(New Position)		 Filing